Analysis of glioblastoma stem cell derived from bone marrow stem cell using high-resolution array-based comparative genomic hybridization
Analysis of glioblastoma stem cell derived from bone marrow stem cell using high-resolution array-based comparative genomic hybridization
批准号:
17390403
负责人:
MINETA Toshihiro
金额:
$9.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dpite great efforts in basic life science and clinical esearch, little progress has been made in mproving the prognosis for patients with glioblastomas. urgical cure of gliomas is impossible in practice because of their high infiltrating activity. The clinical course is dependent upon the biological behavior of the tumor cells. There is increasing evidence that the accumulation of genetic and epigenetic alterations is essential for tumor initiation and progression. Conventional comparative genomic hybridization(metaphase-CGH)_4 has been widely used to screen for chromosomal gains and losses throughout the entiregenome of a tumor. Microarraybased CGH (array-CGH) is a recently developed genomicanalysis technology that enables high-throughputscreening of gene aberrations with sensitivity to detect single gene copy changes. In this study, we employed array CGH formapping of copy number alterations in glioblastomas and analyzed the potential correlation between genomic changes and prognosis … More of patients. We examined whole genomic aberrations of biopsied samples from glioblastomas by array-based comparative genomic hybridization analysis. The highest frequencies of copy number gains were observed on RFC2 (73.3%), EGFR (63.2%), and FGR, ELN, CDKN1C, FES, TOP2A, and ARSA (57.9% each). The highest frequencies of copy number losses were detected on TBR1(52.6%), BMI1 (52.6%), EGR2 (47.4%), DMBT1 (47.4%), MTAP (42.1%), and FGFR2 (42.1%). The copy numbergains of CDKN1C and INS and the copy number losses of TBR1 were significantly correlated with longer survival of patients. High-level amplifications were identified on EGFR, SAS/CDK4, PDGFRA, MDM2, and ARSA. These genes are assumed to be involved in tumorigenesis or progression of glioblastomas. The present study indicates that array-based comparative genomic hybridization analysis has great potential for assessment of copy number changes and altered chromosomal regions of brain tumors. Furthermore, we show that nonlinear analysis methods of whole genome copy number profiles may provide prognostic information about glioblastoma patients. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
脳深部病変としてのグリオーマ -悪性度の高い症例の治療戦略-
胶质瘤作为一种深部脑部病变-高度恶性病例的治疗策略-
DOI:
--
发表时间:
2006
期刊:
CLINICAL NEUROSCIENCE 24
影响因子:
--
作者:
[峯田寿裕, 田渕和雄]
通讯作者:
田渕和雄
DOI:
10.3171/jns.2005.103.2.0284
发表时间:
2005-08-01
期刊:
JOURNAL OF NEUROSURGERY
影响因子:
4.1
作者:
[Vogel, TWA, Vortmeyer, AO, Zhuang, ZP]
通讯作者:
Zhuang, ZP
Olfactory neuroepithelioma : An immunohistochemical and ultrastructural study
嗅神经上皮瘤:免疫组织化学和超微结构研究
DOI:
--
发表时间:
2006
期刊:
Neuropathology 26
影响因子:
--
作者:
[Sugita Y, Kusano K, et al.]
通讯作者:
et al.
グリオーマ : 病態と治療 : ウィルスのゲノム検索(田渕和雄(編))
神经胶质瘤:病理学和治疗:病毒基因组搜索(Kazuo Tabuchi(编辑))
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[峯田寿裕, 田渕和雄]
通讯作者:
田渕和雄
脳深部病変としてのグリオーマ-悪性度の高い症例の治療戦略-
胶质瘤作为一种深部脑部病变-高度恶性病例的治疗策略-
DOI:
--
发表时间:
2006
期刊:
Clinical Neuroscience 24
影响因子:
--
作者:
[田渕和雄, 峯田寿裕]
通讯作者:
峯田寿裕
共 19 条
Detection of viral DNA sequences in human neuro-epithelial tumors
-
批准号:15591532
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2003
-
负责人:MINETA Toshihiro
-
依托单位:
Identification of a differentiation-related gene in the central nervous system using differential display method
-
批准号:09671429
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:MINETA Toshihiro
-
依托单位:
Identification of a differentiation-related gene in the rat central nervous system using differential display method
-
批准号:07671528
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:MINETA Toshihiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
-
批准号:82372327
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马展
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
miR-7联合miR-17-5P小RNA干扰片段共同阻遏胶质母细胞瘤G1/S转化的研究
-
批准号:81000901
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:刘晓智
-
依托单位:
变异型IκBα抑制人类胶质瘤的分子机制
-
批准号:30440016
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2004
-
负责人:吴建梁
-
依托单位: